Pharmaceutical

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology

In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in oncology.

Oct 22, 2024 - 04:00
ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology
In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in oncology.
Read the original article

Tags:

Previous Article

Seaport raises $225m to advance portfolio of neuropsychiatric prodrugs

Next Article

FibroBiologics and Charles River link for chronic disease therapies manufacture

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Senate panel passes a suite of drug pricing bills — but fails to advance one major PBM reform

STAT+: Senate panel passes a suite of drug pricing bill...

May 11, 2023

UCB enters drug discovery collaboration with Aitia

UCB enters drug discovery collaboration with Aitia

Mar 19, 2023

Opinion: California should become the first state to offer a special minimum wage to health care workers

Opinion: California should become the first state to of...

Jul 8, 2023